Fulcrum Therapeutics (FULC) Q3 2024 Earnings

31JulConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.44
-0
0.43
0.87

Details

Expected EPS
-0.412
Actual EPS
0.87
Surprise EPS
1.28
Surprise Percent
+311.17%

Description

Fulcrum Therapeutics (FULC) has reported earnings of 0.87 per share for Q3 2024.

0 Comments

Share your thoughts